OBJECTIVES: Guidelines recommend the avoidance of direct return of pericardial blood based on evidence from coronary surgery. A continuous auto-transfusion system (CATS) can be a good alternative to cardiotomy suction by reinfusing aspirated pericardial blood without the necessity of intermittent collection. To clarify the effects of direct return of pericardial blood in aortic valve replacement (AVR), we compared the effects of cardiotomy suction and an alternative CATS on perioperative coagulofibrinolysis and inflammation systems, and clinical outcomes.
INTRODUCTION
According to recent research, the use of cardiotomy suction as a direct return of aspirated pericardial blood promotes various undesirable systemic responses, probably due to blood interference with the wound tissue factor and changes in inflammatory mediators in the blood [1] [2] [3] [4] . Therefore, guidelines based on evidence from coronary artery bypass grafting (CABG) recommend the avoidance of direct retransfusion of pericardial blood (Class I, Level B) [1] . However, elimination of cardiotomy suction seems still not to be common practice, and no specific standard method for the alternative management of pericardial blood for its reinfusion instead of discarding it has yet been established [5] , although miniaturized cardiopulmonary bypass (CPB) circuits, which are not equipped with cardiotomy suction, are now used in some cardiac operations such as CABG and aortic valve replacement (AVR) [6] [7] [8] [9] [10] [11] .
In CABG, researchers have reported that processing of pericardial blood using alternative cell-saving devices instead of cardiotomy suction is practicable and advantageous [12] [13] [14] . The cell-saving devices used in those studies require the collection of a certain amount of aspirated blood before processing begins, and therefore, results in a time lag that is more disadvantageous than cardiotomy suction. In contrast to such intermittent cell-saving devices, a continuous auto-transfusion system (CATS®, Fresenius Kabi Deutschland GmBH, Bad Homburg, Germany) has a unique capacity to continuously process and return blood [15, 16] and could be a more justifiable alternative to cardiotomy suction in various kinds of cardiac surgeries than other intermittent cellsaving devices.
Perioperative activation of coagulation, fibrinolysis and inflammation systems associated with CPB can lead to various adverse outcomes, such as bleeding disorder, vital organ dysfunction, respiratory failure and infectious complications, particularly in highrisk patients [17, 18] . It was previously believed that activation of coagulation and fibrinolysis was inevitable in cardiac operations with CPB [19] [20] [21] . However, our group recently demonstrated that processing of pericardial blood with the use of an alternative intermittent cell-saving device could completely suppress the coagulation and fibrinolysis responses associated with the use of CPB in CABG [12] . In CABG, the accumulated blood in the pericardial cavity might be active in the coagulation system, because it includes continuously oozing blood from the raw dissected bed of harvested internal thoracic arteries even before heparinization during the period of the graft harvest. Therefore, systemic responses in valve surgeries caused by the return of pericardial blood through cardiotomy suction are supposed to be different from CABG. In the present prospective clinical study, we evaluated the perioperative effects of pericardial blood on coagulofibrinolysis and inflammation systems in AVR and the early clinical outcomes of this procedure by comparing operations performed with cardiotomy suction or, alternatively, CATS.
MATERIALS AND METHODS

Study subjects
Between April 2009 and April 2011, 40 patients who were planned to undergo elective, primary AVRs at Osaka City University Hospital (Osaka, Japan) were prospectively allocated to one of the following suction strategies during CPB by preoperatively drawing lots: retransfusion of pericardial blood using cardiotomy suction (non-Cell-Saver group, n = 20) or CATS (Cell-Saver group, n = 20), which continuously processes suctioned blood by washing and centrifugation with a saline solution that concentrates it to 65% haematocrit. The required number of patients for verifying statistical significance was calculated to be 15 in each group by using a sample size formula with α = 0.05 and power 1−β = 0.8.
where Pp = 0.4, Pu = 0, P = (Pp + Pu)/2, Zα=1.96, Zβ= 0.842, based on our previous data [12] . Thus, we recruited 20 patients in one group. Surgeons and perfusionists were informed of the allocated group in the operating room just before starting the operation, but physicians who postoperatively treated patients in the intensive care unit were not. Exclusion criteria included coagulofibrinolysis disorders, renal or liver dysfunction, left ventricular dysfunction and inflammatory or malignant disease. This study was approved by the Institutional Review Board of Osaka City University Hospital, and informed consent was obtained from all patients.
Study protocols
Anaesthetic protocol and surgical procedure. A standardized anaesthetic protocol was used for all patients, as previously described [12] . No patient received perioperative corticosteroids, aprotinin or tranexamic acid. A median sternotomy approach was used in all patients. Bovine heparin (300 IU/kg) was administered and then CPB was established with an arterial cannula to the ascending aorta and a twostage cannula through the right atrial appendage. A left ventricular vent was inserted via the right upper pulmonary vein, and the blood from the vent was returned to the venous reservoir. The strategies for retransfusion of pericardial blood in each group are described precisely below. Additional heparin was administered to maintain an activated clotting time of >400 s. During CPB, a non-pulsatile perfusion flow of 2.4 l/min/m 2 body surface area was maintained under moderate systemic hypothermia (rectal temperature, 32°C), and the mean arterial pressure was controlled within a range of 50-80 mmHg.
The same CPB circuits were used in the two groups and consisted of a hollow-fiber membrane oxygenator (Affinity NT Oxygenator CB 511), a centrifugal blood pump (Bio-Pump, CBBPX80), an arterial filter (Affinity Arterial Filter, CB351) and a hard-shell venous reservoir (Affinity CVR Reservoir, 61399409462); all four components from Medtronic Cardiac Surgery, Minneapolis, MN, USA. The components of the circuits were coated with covalently bonded heparin. The circuits were primed with identical fluid (1300 ml), a mixture of 1000 ml lactated Ringer's solution, 200 ml mannitol (200 mg/ml) and 100 ml sodium bicarbonate (84 mg/ml).
After aortic cross-clamping, identical cold blood cardioplegia was administered through the aortic root, followed by intermittent administration in antegrade (selectively into the orifices of coronary arteries) or retrograde fashion. Through a partial transverse aortotomy, the aortic valve cusps were excised, the calcified annulus valve removed and the size of the annulus measured. In consideration of both the size and the preference that the patient had expressed after our preoperative explanation, a mechanical or bioprosthetic valve of the appropriate size was chosen. Pledgeted 2-0 polyester sutures were placed in a para-or supra-annular position around the annulus. In 5 patients (1 in the non-Cell-Saver group and 4 in the Cell-Saver group, P = 0.342), an annular enlargement by a Nick's single patch procedure was required due to a small aortic annulus. After closing the aortotomy in a doublesuture fashion, the aortic clamp was released and both the function of the implanted prosthetic valve and general cardiac function evaluated by transoesophageal echocardiography during weaning from CPB. No additional aortic cross-clamp was needed in any patient. Heparin was neutralized with 4.5 mg/kg of protamine and haemostasis achieved. The blood remaining in the CPB circuit was processed and reinfused through CATS. All patients were admitted postoperatively to the intensive care unit. The blood from the chest drains was discarded.
Retransfusion strategy for pericardial suction blood Non-Cell-Saver group. During CPB, the pericardial blood was suctioned by cardiotomy suction and returned to the venous reservoir; however, CATS was used only when needed to quickly aspirate blood and keep the surgical vision in the aortic valve annulus. At all other times, the pericardial blood was suctioned by CATS and the processed and concentrated blood intravenously retransfused.
Cell-Saver group. Throughout the operation, the pericardial blood was suctioned and processed by CATS without using cardiotomy suction. During CPB, the processed blood was returned continuously to the venous reservoir. At all other times, the processed blood was retransfused intravenously, as in the non-Cell-Saver group.
Blood transfusion protocols. The protocols for blood product use were similar in all patients, packed red blood cells being transfused to strictly maintain the haematocrit at 23% or more during CPB and 28% or more after termination of CPB as well as to stabilize the hemodynamic status.
Data collection and measurements
Blood samples were obtained from a radial arterial catheter or the arterial side of the CPB circulation at the following nine times: T1, before induction of anaesthesia; T2 and T3, 10 min and 1 h after initiation of CPB, respectively; T4, 10 min after aortic declamping; T5, 5 min after protamine administration; T6, T7 and T8, 1, 3 and 6 h after termination of CPB, respectively and T9, on the first postoperative morning. The other citrated samples were centrifuged at 3000 g for 10 min and the plasma stored at −80°C for later analysis.
The coagulation and fibrinolysis markers activated partial thromboplastin time, international normalized ratio of prothrombin time, antithrombin III, thrombin-antithrombin III complex (TAT), fibrinogen, fibrinogen degeneration products (FDPs), D-dimer, plasminogen, plasmin-α2 plasmin inhibitor complex (PIC) and plasminogen activator inhibitor-1 (PAI-1) were measured as previously described [12] . 
Statistical analysis
Data were analysed using Dr SPSS II for Windows software (SPSS, Troy, NY, USA). Numerical variables were expressed as the mean ± standard deviation and analysed using the parametric Student's t-test or non-parametric Mann-Whitney U-test for comparisons between two groups, as appropriate. Categorical variables were expressed as numbers or percentages of patients and compared using the χ 2 test and Fisher's exact test, as appropriate. Repeated-measures analysis of variance were performed to compare the laboratory variables between the two groups. If significant differences were detected, Bonferroni's corrected comparisons with Student's t-test were made at individual observation times between the two groups, as appropriate. The value of significance was set at P < 0.05.
RESULTS
Preoperative clinical data
There were no significant differences between the two groups in preoperative data (Table 1) . No patient was excluded from the study.
Haematocrit and platelet count
No significant differences between the two groups were found in perioperative changes in haematocrit or platelet counts (Fig. 1 ).
Coagulation and fibrinolysis systems
No significant differences between the two groups were seen in perioperative values for activated clotting time, activated partial thromboplastin time, international normalized ratio of prothrombin time, fibrinogen, plasminogen or antithrombin III (Table 2 and Fig. 2A) . The perioperative concentrations of TAT, FDPs, D-dimer and PIC differed significantly between the two groups from T2 or T3 through T7 or T8 (P < 0.05 for each variable; Fig. 2B-E) . In the non-Cell-Saver group, the concentrations of TAT, FDPs, D-dimer and PIC increased during CPB, peaking at T5, and then gradually decreased to concentrations comparable with those of the Cell-Saver group on the first postoperative morning (Fig. 2B-E) . The perioperative concentrations of PAI-1 were not significantly different between the two groups (Fig. 2F ).
Inflammation systems
There were no significant differences between the two groups in perioperative changes in all measured inflammation markers, namely IL-6, 8 and 10 as well as TNF-α (Fig. 3 ). 
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Intra-and postoperative clinical data
Relevant intra-and postoperative clinical data are summarized in Table 3 . CATS is not associated with any technical problems regarding CPB management and no patient required a conversion to the use of cardiotomy suction. There were no significant differences between the two groups in intraoperative clinical data. Postoperative blood loss during the first 12 and 24 h tended to be greater in the non-Cell-Saver group than in the Cell-Saver group, although these differences were not significant. Total use of packed red blood cells and fresh frozen plasma were comparable between the two groups, although the amount of packed red blood cells used in the Cell-Saver group tended to be more during CPB, and it was significantly less from after weaning of CPB to the first postoperative morning compared with that in the non-Cell-Saver group (P = 0.004).
DISCUSSION
This prospective study demonstrated that, in AVR, substitution of cardiotomy suction by CATS for reinfusion of pericardial blood suppressed the activations of the coagulation and fibrinolysis systems associated with the use of CPB. The comparable volumes of total perioperative transfusion and postoperative blood loss in the two groups indicated that the use of CATS instead of cardiotomy suction could be justified with regard to the amount of perioperative blood product use. Regarding operative procedures and CPB management, CATS can be substituted for cardiotomy suction without creating any technical problems in AVRs with a standard CPB. With regard to the coagulation system, the significant suppression of increases in TAT during CPB in the Cell-Saver group indicated that direct return of pericardial blood by cardiotomy Data are expressed as mean ± SD. T1: before induction of anaesthesia; T2 and T3: 10 min and 1 h after initiation of CPB, respectively; T4: 10 min after aortic declamping; T5: 5 min after protamine administration; T6, T7 and T8: 1, 3 and 6 h after termination of CPB, respectively; T9: first postoperative morning. ACT: activated clotting time; APTT: activated partial thromboplastin time; NA: not applicable; PT-INR: international normalized ratio of prothrombin time. suction was responsible for increases in TAT. This is presumably because blood contact with the wound tissue factor in the surgical field activates the extrinsic coagulation pathway of the blood and generates a considerable amount of thrombin [2, 22] . The process of CATS eliminates thrombin in the pericardial blood, as demonstrated by findings in the Cell-Saver group. Furthermore, the suppression of increases in TAT during CPB in the Cell-Saver group indicates that the standard heparinization completely inhibits thrombin generation through the intrinsic coagulation pathway promoted by contact between blood and the non-endotheliallined CPB circuit. The use of cardiotomy suction is also evidently responsible for the activation of fibrinolysis associated with CPB, as shown by the completely suppressed markers FDPs, D-dimer and PIC during CPB in the Cell-Saver group. The trends in the values for these fibrinolysis markers paralleled the trends in increases in TAT. These results are consistent with the fact that thrombin is an important enzyme for initiating the serial activation of both coagulation and fibrinolysis. PAI-l, a marker of fibrinolysis inhibition, gradually increased after the termination of CPB, peaking at T8; the trends were comparable between the two groups. The fact that activation of fibrinolysis is followed by its inhibition explains the time lag between the peaks in FDPs, D-dimer and PIC at T5 and those of PAI-1 at T8 in the non-Cell-Saver group.
Perioperative activation of inflammatory factors in association with CPB appears to be unavoidable whether blood is returned directly, as in cardiotomy suction, or after being processed by various cell-saving devices. In the current study, perioperative changes in the proinflammatory markers such as IL-6, -8 and TNF-α and the anti-inflammatory marker such as IL-10 were identical in the two groups. The postoperative maximum values for white blood cell counts and C-reactive protein were also no different between the two groups. In contrast, Westerberg et al. [3] found that elimination of cardiotomy suction reduced increases in IL-6 and TNF-α. One possible explanation for this discrepancy between the studies is the fact that Westerberg et al. discarded pericardial blood, whereas we retransfused this blood by CATS. The comparable activation in the inflammation system even with the use of a cell-saving device as an alternative to cardiotomy suction is possibly explained by the fact that cell-saving devices do not completely remove proinflammation products [15, 16] .
ORIGINAL ARTICLE
Another possibility that we have to consider is that the cell-saving device itself might activate the inflammation system by shear stress with the process of centrifugation. We demonstrated that CATS is a practicable alternative to cardiotomy suction in AVR using a standard CPB with comparable outcomes between the two groups regarding blood conservation. The marked suppression of the activation of coagulation and fibrinolysis could explain the significantly smaller volumes of packed red blood cells required after CPB in the Cell-Saver group. However, it is still not possible to reach a definite conclusion as to whether cell-saving devices are superior to cardiotomy suction with regard to perioperative blood conservation, because only a few clinical studies have addressed this point, and the types of surgery and protocols for managing pericardial blood were not identical among the studies. Contrary to our current result, Rubens et al. [23] reported that, in a study of CABG and AVR, the use of a cell-saving device was associated with requirements for greater volumes of blood products and more postoperative blood loss than was cardiotomy suction. However, their results are not strictly comparable with ours because they used an intermittent cell-saving device and we used CATS. The unique capacity of CATS to perform continuous processing could contribute to the fact that our two groups had comparable volumes of transfusion and postoperative blood loss. Regarding the requirements for fresh frozen plasma, some previous studies have concluded that the substitution of cell-saving devices for cardiotomy suction increases the requirements for fresh frozen plasma [4, 22] . This finding indicates that loss of plasma and platelets through processing by cell-saving devices can be a disadvantage for blood conservation, particularly when a considerable volume of blood is processed and returned. The use of a cell-saving device, furthermore, could be associated with shear stress of red blood cells by the process of centrifugation, particularly when considerable amounts of pericardial blood was retransfused by the cell-saving device. In consideration of these points, further studies are warranted to establish a cut-off point for the volume of suctioned blood that indicates the need for conversion from the use of a cell-saving device to cardiotomy suction [5] .
In our experience, the substitution of CATS for cardiotomy suction is not associated with any technical disadvantages in the operative procedures of AVR and management of CPB. Therefore, CATS could be a superior substitution for cardiotomy suction to other intermittent cell-saving devices in various types of cardiovascular surgeries. However, our findings in AVR procedures might not be applicable to mitral valve surgery or other complicated cardiac surgeries because they characteristically involve the collection of a higher volume of pericardial blood during CPB than that in AVR. Further clinical investigations are necessary to clarify the usefulness of CATS as an alternative to cardiotomy suction, particularly in cardiac surgery that involves relatively large volumes of pericardial blood.
This study has several limitations. First, the sample size was not large enough to assess the statistical significance of differences between the groups in clinical outcomes, such as postoperative blood loss and required transfusions. In this study, we could not consider that the elimination of cardiotomy suction could contribute to the avoidance of transfusion, because haemodilution due to the priming volume of CPB circuit could easily result in low haematocrit in the current patients, whose body size is extremely small with a mean body surface area of 1.50, and we applied the strict protocol of blood product use in order to avoid adverse outcomes related to low haematocrit, particularly during CPB [24] . The present study, furthermore, aimed to precisely elucidate how the elimination of cardiotomy suction affects the perioperative responses of coagulofibrinolysis and inflammation systems under the identical transfusion protocol, and did not aim to avoid transfusion. Secondly, we did not quantify the volume of blood retransfused through cardiotomy suction because the additional cardiotomy reservoir and the temporary retention of blood in that reservoir required for such quantification might have affected the haemostatic results. Thirdly, platelet viability and function were not measured, although these factors were associated with perioperative haemostasis. Fourthly, the use of a left ventricular vent might be considered to affect the current results, but Fabre et al. [25] demonstrated that the use of a left ventricular vent with suction forces poorly contributed to blood trauma and activation.
In summary, the current study presents the following three findings. First, direct return of pericardial blood by cardiotomy suction is responsible for perioperative activation of coagulation and fibrinolysis systems in AVR, and using the alternative of CATS markedly suppresses this activation. This result, which is the first specifically concerning valve surgeries, supports the published guideline recommending the avoidance of direct return of pericardial blood [1] . Secondly, neither direct return of pericardial blood nor returning it after processing it by CATS suppresses the activation of inflammatory factors associated with the use of CPB. Thirdly, AVR using CATS instead of cardiotomy suction could be justified by the comparable outcomes in the two groups regarding the amount of perioperative blood product use, and the characteristic of the continuous process of CATS appears to advantageously contribute to the outcomes. All the above findings could be helpful in establishing ideal strategies for eliminating the use of cardiotomy suction and alternatively managing pericardial blood, resulting in less-invasive valve surgeries with marked suppression of coagulofibrinolysis responses.
